Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Paediatric HIV infection in Western Africa: the long way to the standard of care.

Tchidjou HK, Maria Martino A, Goli LP, Diop Ly M, Zekeng L, Samba M, Maiolo S, Palma P, Pontrelli G, Mancino G, Rossi P, Colizzi V.

J Trop Pediatr. 2012 Dec;58(6):451-6. doi: 10.1093/tropej/fms015. Epub 2012 Apr 23.

PMID:
22529318
2.

A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.

Mbopi-Keou FX, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Giguere JF, Domingo MC, Piret J, Tsague L, Zekeng L, Mwatha A, Mâsse B, Bergeron MG.

Contraception. 2009 Nov;80(5):484-92. doi: 10.1016/j.contraception.2009.03.020. Epub 2009 May 23.

PMID:
19835725
3.

The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004.

Brennan CA, Bodelle P, Coffey R, Devare SG, Golden A, Hackett J Jr, Harris B, Holzmayer V, Luk KC, Schochetman G, Swanson P, Yamaguchi J, Vallari A, Ndembi N, Ngansop C, Makamche F, Mbanya D, Gürtler LG, Zekeng L, Kaptué L.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):432-9. doi: 10.1097/QAI.0b013e31818a6561.

PMID:
18931623
4.

Determinants of retention in care in an antiretroviral therapy (ART) program in urban Cameroon, 2003-2005.

Tsague L, Koulla SS, Kenfak A, Kouanfack C, Tejiokem M, Abong T, Mbangue M, Mapoure YN, Essomba C, Mosoko J, Pouillot R, Menyeng L, Epee H, Tchuani C, Zoung-Kanyi AC, Bella LA, Zekeng L.

Pan Afr Med J. 2008 Jul 4;1:2.

5.

Functional domains of the human immunodeficiency virus type 1 Nef protein are conserved among different clades in Cameroon.

Ndjomou J, Zekeng L, Kaptue L, Däumer M, Kaiser R, Matz B, Kupfer B.

AIDS Res Hum Retroviruses. 2006 Oct;22(10):936-44.

PMID:
17067262
6.

HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon.

Vergne L, Diagbouga S, Kouanfack C, Aghokeng A, Butel C, Laurent C, Noumssi N, Tardy M, Sawadogo A, Drabo J, Hien H, Zekeng L, Delaporte E, Peeters M.

Antivir Ther. 2006;11(5):575-9.

PMID:
16964825
7.

HIV genetic diversity in Cameroon: possible public health importance.

Ndongmo CB, Pieniazek D, Holberg-Petersen M, Holm-Hansen C, Zekeng L, Jeansson SL, Kaptue L, Kalish ML.

AIDS Res Hum Retroviruses. 2006 Aug;22(8):812-6.

8.

Antiretroviral drug resistance and routine therapy, Cameroon.

Laurent C, Kouanfack C, Vergne L, Tardy M, Zekeng L, Noumsi N, Butel C, Bourgeois A, Mpoudi-Ngolé E, Koulla-Shiro S, Peeters M, Delaporte E.

Emerg Infect Dis. 2006 Jun;12(6):1001-4.

9.

Prevention of mother-to-child transmission of HIV in Cameroon: experiences from the University Teaching Hospital in Yaounde (Cameroon).

Kouam L, Nsangou I, Mbanya D, Nkam M, Kongnyuy EJ, Ngassa P, Tebeu PM, Elobe N, Kamgaing NG, Zekeng L, Doh AS.

Zentralbl Gynakol. 2006 Apr;128(2):82-6.

PMID:
16673250
10.

Evaluation of FDA licensed HIV assays using plasma from Cameroonian blood donors.

Lee S, Hu J, Tang S, Wood O, Francis K, Machuca A, Rios M, Daniel S, Vockley C, Awazi B, Zekeng L, Hewlett I.

J Med Virol. 2006;78 Suppl 1:S22-3.

PMID:
16622873
11.

A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon.

Kurbanov F, Tanaka Y, Fujiwara K, Sugauchi F, Mbanya D, Zekeng L, Ndembi N, Ngansop C, Kaptue L, Miura T, Ido E, Hayami M, Ichimura H, Mizokami M.

J Gen Virol. 2005 Jul;86(Pt 7):2047-56.

PMID:
15958684
12.

Enfuvirtide binding domain is highly conserved in non-B HIV type 1 strains from Cameroon, West Central Africa.

Aghokeng AF, Ewane L, Awazi B, Nanfack A, Delaporte E, Zekeng L, Peeters M.

AIDS Res Hum Retroviruses. 2005 May;21(5):430-3.

PMID:
15929708
13.

Near-full-length genomic sequence of a human immunodeficiency type 1 subtype G strain from Cameroon.

Holzmayer V, Zekeng L, Kaptué L, Gürtler L, Devare SG, Hackett J Jr.

AIDS Res Hum Retroviruses. 2005 May;21(5):414-9. No abstract available.

PMID:
15929705
14.

Field assessment of generic antiretroviral drugs: a prospective cohort study in Cameroon.

Bourgeois A, Laurent C, Mougnutou R, Nkoué N, Lactuock B, Ciaffi L, Liégeois F, Andrieux-Meyer I, Zekeng L, Calmy A, Mpoudi-Ngolé E, Delaporte E.

Antivir Ther. 2005;10(2):335-41.

PMID:
15865228
15.

Genetic diversity of HIV type 1 in rural eastern Cameroon.

Ndembi N, Takehisa J, Zekeng L, Kobayashi E, Ngansop C, Songok EM, Kageyama S, Takemura T, Ido E, Hayami M, Kaptue L, Ichimura H.

J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1641-50.

PMID:
15577423
16.

Evaluation of four simple/rapid assays and two fourth-generation ELISAs for the identification of HIV infection on a serum panel representing the HIV-1 group M genetic diversity in Cameroon.

Aghokeng AF, Ewane L, Awazi B, Nanfack A, Delaporte E, Peeters M, Zekeng L.

J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1632-40.

PMID:
15577422
17.

Adolescent sexuality and the HIV epidemic in Yaoundé, Cameroon.

Lydiè N, Robinson NJ, Ferry B, Akam E, De Loenzien M, Zekeng L, Abega S.

J Biosoc Sci. 2004 Sep;36(5):597-616.

PMID:
15446354
18.

Construction and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr- and nef-negative derivatives.

Tebit DM, Zekeng L, Kaptué L, Gürtler L, Fackler OT, Keppler OT, Herchenröder O, Kräusslich HG.

Virology. 2004 Sep 1;326(2):329-39.

19.

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.

Laurent C, Kouanfack C, Koulla-Shiro S, Nkoué N, Bourgeois A, Calmy A, Lactuock B, Nzeusseu V, Mougnutou R, Peytavin G, Liégeois F, Nerrienet E, Tardy M, Peeters M, Andrieux-Meyer I, Zekeng L, Kazatchkine M, Mpoudi-Ngolé E, Delaporte E.

Lancet. 2004 Jul 3-9;364(9428):29-34.

PMID:
15234853
20.

Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains.

Eshleman SH, Hackett J Jr, Swanson P, Cunningham SP, Drews B, Brennan C, Devare SG, Zekeng L, Kaptué L, Marlowe N.

J Clin Microbiol. 2004 Jun;42(6):2711-7.

21.

Induced abortion among women attending antenatal clinics in Yaounde, Cameroon.

Mosoko JJ, Delvaux T, Glynn JR, Zekeng L, Macauley I, Buve A.

East Afr Med J. 2004 Feb;81(2):71-7.

PMID:
15125089
22.

Protease mutations in HIV-1 non-B strains infecting drug-naive villagers in Cameroon.

Konings FA, Zhong P, Agwara M, Agyingi L, Zekeng L, Achkar JM, Ewane L, Saa, Afane Ze E, Kinge T, Nyambi PN.

AIDS Res Hum Retroviruses. 2004 Jan;20(1):105-9.

PMID:
15008125
23.

Defining human immunodeficiency virus (HIV) type 1 immunotypes with six human monoclonal antibodies.

Nádas A, Zhong P, Burda S, Zekeng L, Urbanski M, Gorny MK, Zolla-Pazner S, Nyambi PN.

AIDS Res Hum Retroviruses. 2004 Jan;20(1):55-65.

PMID:
15000699
24.

Does increased general schooling protect against HIV infection? A study in four African cities.

Glynn JR, Caraël M, Buvé A, Anagonou S, Zekeng L, Kahindo M, Musonda R; Study Group on Heterogeneity of HIV Epidemics in African Cities.

Trop Med Int Health. 2004 Jan;9(1):4-14.

25.

Genetic and biological properties of HIV type 1 isolates prevalent in villagers of the Cameroon equatorial rain forests and grass fields: further evidence of broad HIV type 1 genetic diversity.

Zhong P, BUrda S, Konings F, Urbanski M, Ma L, Zekeng L, Ewane L, Agyingi L, Agwara M, Saa, Afane ZE, Kinge T, Zolla-Pazner S, Nyambi P.

AIDS Res Hum Retroviruses. 2003 Dec;19(12):1167-78.

PMID:
14717120
26.

Near full-length genomes of 15 HIV type 1 group O isolates.

Yamaguchi J, Bodelle P, Kaptué L, Zekeng L, Gürtler LG, Devare SG, Brennan CA.

AIDS Res Hum Retroviruses. 2003 Nov;19(11):979-88.

PMID:
14678605
27.
28.

Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage.

Vergne L, Bourgeois A, Mpoudi-Ngole E, Mougnutou R, Mbuagbaw J, Liegeois F, Laurent C, Butel C, Zekeng L, Delaporte E, Peeters M.

Virology. 2003 Jun 5;310(2):254-66.

29.
30.

Nucleotide sequence analysis of the accessory genes of HIV-1 group O isolates.

Vallejo A, Gurtler L, Zekeng L, Hewlett IK.

Virus Res. 2003 Feb;91(2):189-93.

PMID:
12573497
31.

HIV infection in rural villages of Cameroon.

Nyambi P, Zekeng L, Kenfack H, Tongo M, Nanfack A, Nkombe I, Ndonko F, Shang J, Burda S, Mbah H, Agyingi L, Zhong P, Nádas A, Zolla-Pazner S, Marmor M.

J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):506-13.

PMID:
12473839
32.

HIV type 1 group M clades infecting subjects from rural villages in equatorial rain forests of Cameroon.

Zhong P, Burda S, Urbanski M, Kenfack H, Tongo M, Heyndrickx L, Nanfack A, Shang J, Agyingi L, Zolla-Pazner S, Zekeng L, Nyambi P.

J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):495-505.

PMID:
12473838
33.

Prevention works. Cameroon.

Zekeng L.

Integration. 1998 Fall;(57):26-8.

PMID:
12294623
34.

No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study.

Laurent C, Bourgeois A, Faye MA, Mougnutou R, Seydi M, Gueye M, Liégeois F, Kane CT, Butel C, Mbuagbaw J, Zekeng L, Mboup S, Mpoudi-Ngolé E, Peeters M, Delaporte E.

J Infect Dis. 2002 Aug 15;186(4):486-92. Epub 2002 Jul 19.

PMID:
12195375
35.

Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection: a randomized controlled trial.

Roddy RE, Zekeng L, Ryan KA, Tamoufé U, Tweedy KG.

JAMA. 2002 Mar 6;287(9):1117-22.

PMID:
11879108
36.

Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters.

Yamaguchi J, Vallari AS, Swanson P, Bodelle P, Kaptué L, Ngansop C, Zekeng L, Gürtler LG, Devare SG, Brennan CA.

AIDS Res Hum Retroviruses. 2002 Mar 1;18(4):269-82.

PMID:
11860674
37.

Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon.

Tebit DM, Zekeng L, Kaptué L, Salminen M, Kräusslich HG, Herchenröder O.

AIDS Res Hum Retroviruses. 2002 Jan 1;18(1):39-48.

PMID:
11804555
38.

Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon.

Ndjomou J, Kupfer B, Kochan B, Zekeng L, Kaptue L, Matz B.

J Med Virol. 2002 Feb;66(2):179-86.

PMID:
11782926
39.

Naturally occurring sequence polymorphisms within HIV type 1 group O protease.

Luk KC, Kaptué L, Zekeng L, Soriano V, Gürtler L, Devare SG, Schochetman G, Hackett J Jr.

AIDS Res Hum Retroviruses. 2001 Nov 1;17(16):1555-61.

PMID:
11709100
40.

The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations.

Weiss HA, Buvé A, Robinson NJ, Van Dyck E, Kahindo M, Anagonou S, Musonda R, Zekeng L, Morison L, Caraël M, Laga M, Hayes RJ; Study Group on Heterogeneity of HIV Epidemics in African Cities.

AIDS. 2001 Aug;15 Suppl 4:S97-108.

PMID:
11686471
41.

The epidemiology of trichomoniasis in women in four African cities.

Buvé A, Weiss HA, Laga M, Van Dyck E, Musonda R, Zekeng L, Kahindo M, Anagonou S, Morison L, Robinson NJ, Hayes RJ; Study Group on Heterogeneity of HIV Epidemics in African Cities.

AIDS. 2001 Aug;15 Suppl 4:S89-96.

PMID:
11686470
42.

The epidemiology of gonorrhoea, chlamydial infection and syphilis in four African cities.

Buvé A, Weiss HA, Laga M, Van Dyck E, Musonda R, Zekeng L, Kahindo M, Anagonou S, Morison L, Robinson NJ, Hayes RJ; Study Group on Heterogeneity of HIV Epidemics in African Cities.

AIDS. 2001 Aug;15 Suppl 4:S79-88.

PMID:
11686469
43.

Multicentre study on factors determining differences in rate of spread of HIV in sub-Saharan Africa: methods and prevalence of HIV infection.

Buvé A, Caraël M, Hayes RJ, Auvert B, Ferry B, Robinson NJ, Anagonou S, Kanhonou L, Laourou M, Abega S, Akam E, Zekeng L, Chege J, Kahindo M, Rutenberg N, Kaona F, Musonda R, Sukwa T, Morison L, Weiss HA, Laga M; Study Group on Heterogeneity of HIV Epidemics in African Cities.

AIDS. 2001 Aug;15 Suppl 4:S5-14.

PMID:
11686465
44.

The multicentre study on factors determining the differential spread of HIV in four African cities: summary and conclusions.

Buvé A, Caraël M, Hayes RJ, Auvert B, Ferry B, Robinson NJ, Anagonou S, Kanhonou L, Laourou M, Abega S, Akam E, Zekeng L, Chege J, Kahindo M, Rutenberg N, Kaona F, Musonda R, Sukwa T, Morison L, Weiss HA, Laga M; Study Group on Heterogeneity of HIV Epidemics in African Cities.

AIDS. 2001 Aug;15 Suppl 4:S127-31. No abstract available.

PMID:
11686461
45.

HIV-1 subtypes and the HIV epidemics in four cities in sub-Saharan Africa.

Morison L, Buvé A, Zekeng L, Heyndrickx L, Anagonou S, Musonda R, Kahindo M, Weiss HA, Hayes RJ, Laga M, Janssens W, van der Groen G; Study Group on Heterogeneity of HIV Epidemics in African Cities.

AIDS. 2001 Aug;15 Suppl 4:S109-16.

PMID:
11686459
46.

Factors influencing the difference in HIV prevalence between antenatal clinic and general population in sub-Saharan Africa.

Glynn JR, Buvé A, Caraël M, Musonda RM, Kahindo M, Macauley I, Tembo F, Zekeng L; Study Group on Heterogeneity of HIV Epidemics in African Cities.

AIDS. 2001 Sep 7;15(13):1717-25.

PMID:
11546948
47.

Natural infection of wild-born mandrills (Mandrillus sphinx) with two different types of simian immunodeficiency virus.

Takehisa J, Harada Y, Ndembi N, Mboudjeka I, Taniguchi Y, Ngansop C, Kuate S, Zekeng L, Ibuki K, Shimada T, Bikandou B, Yamaguchi-Kabata Y, Miura T, Ikeda M, Ichimura H, Kaptué L, Hayami M.

AIDS Res Hum Retroviruses. 2001 Aug 10;17(12):1143-54.

PMID:
11522184
48.

Update on HIV/SIV infections in Cameroon.

Zekeng L.

Philos Trans R Soc Lond B Biol Sci. 2001 Jun 29;356(1410):799. Review.

49.

Is long postpartum sexual abstinence a risk factor for HIV?

Glynn JR, Buvé A, Caraël M, Macauley IB, Kahindo M, Musonda RM, Zekeng L.

AIDS. 2001 May 25;15(8):1059-61. No abstract available.

PMID:
11399990
50.

Decreased fertility among HIV-1-infected women attending antenatal clinics in three African cities.

Glynn JR, Buvé A, Caraël M, Kahindo M, Macauley IB, Musonda RM, Jungmann E, Tembo F, Zekeng L.

J Acquir Immune Defic Syndr. 2000 Dec 1;25(4):345-52.

PMID:
11114835

Supplemental Content

Loading ...
Support Center